Arvid Carlsson

Arvid Carlsson is a Swedish scientist well known for his work on dopamine (neurotransmitter) and its effects in Parkinson’s disease. Carlsson also received the Nobel Prize in Physiology or Medicine 2000 in recognition of his work. He shared the prize with Eric Kandel and Paul Greengard.

Carlsson developed a method for measurement of dopamine levels in the brain tissues. He discovered high levels of dopamine in the basal ganglia. Carlsson also showed that the administration of Reserpine (a drug substance) to animals decreased dopamine levels causing loss of movement controls. This effect was similar to symptoms of Parkinson’s disease. He alleviated the symptoms using L-Dopa (dopamine precursor) which is still the most commonly used treatment in Parkinson’s disease.

Carlsson received the Wolf Prize in Medicine 1979 and Japan Prize 1994.

Public Rating
46 points
Academy Rating
1036 points
Overall Rating
1082 points
Biologist BIOLOGIST (Neurotransmitter dopamine and its effects in Parkinson's disease)
Arvid Carlsson
Superstar Rank: #11
Previous Next

Recent Findings From Arvid Carlsson

Subscribe by RSS

No record yet.

1947 Magnus Blix’ Prize, University of Lund, Sweden

1970 First Annual James Parkinson Lecture and Award, New York

1970 Pehr Dubb’s Gold Medal, The Medical Society of Gothenburg

1974 Anders Jahre’s Medical Prize, University of Olso, Norway

1975 Stanley R Dean Lecture and Award, Phoenix, Arizona

1975 Anna-Monika Stiftung, 1st Prize, for research on antidepressants and neuroleptics

1979 Wolf Prize in Medicine, Jersualem, (together with RW Sperry and O Hornykiewicz)

1981 Björkénska Priset, University of Uppsala, Sweden

1982 Gairdner Foundation Award, Toronto, Canada

1985 Hilda and Alfred Eriksson’s Prize, The Royal Swedish Academy of Science

1989 The Second Annual Bristol-Myers Award for Distinguished Achievement in Neuroscience Research, New York (together with J Axelrod and P Greengard)

1990 The Paul Hoch Prize, American Psychopathological Association, New York

1990 The Fred Springer Award, American Parkinson Disease Association, Miami, FL

1991 William K Warren Schizophrenia Research Award, Tucson, AZ

1992 The Open Mind Award in Psychiatry, Janssen Research Foundation, Paris, together with H Hippius and H van Praag

1992 The Julius Axelrod Medal, The Cathecholamine Club, Anaheim, CA

1994 The Japan Prize, in Psychology and Psychiatry, The Science and Technology Found

1994 The Lieber Prize for research in schizophrenia, USA

1995 The Research Prize of the Lundbeck Foundation, Roskilde, Denmark

1995 The Robert J and Claire Pasarow Foundation Award for Neuropsychiatric Research

1996 Gold Medal and Honorary Diploma, The Swedish Parkinson Association

1997 Kraepelin-Medaillie in Gold, Max-Planck Institut für Psychiatrie, München

1998 Gold Medal, Society of Biological Psychiatry, Toronto, Canada

1999 Gold Medal, Distinguished Lecture and Award, University of Bari, Italy

1999 Antonio Feltrinelli International Award, Accademia dei Lincei, Rome

2000 Nobel Prize in Physiology or Medicine

Rung, JP; Rung, E; Johansson, AM; Svensson, K; Carlsson, A; Carlsson, ML Effects of the dopamine stabilizers (S)-(-)-OSU6162 and ACR16 on prolactin secretion in drug-naive and monoamine-depleted rats. Naunyn-Schmiedeberg’s archives of pharmacology 2011;384(1):39-45.

Starck, G; Carlsson, A; Ljungberg, M; Forssell-Aronsson, E k-space analysis of point-resolved spectroscopy (PRESS) with regard to spurious echoes in in vivo (1)H MRS. NMR in biomedicine 2009;22(2):137-47.

Carlsson, A; Carlsson, ML Adaptive properties and heterogeneity of dopamine D(2) receptors – pharmacological implications. Brain research reviews 2008;58(2):374-8.

Starck, G; Ljungberg, M; Nilsson, M; Jönsson, L; Lundberg, S; Ivarsson, T; Ribbelin, S; Ekholm, S; Carlsson, A; Forssell-Aronsson, E; Carlsson, ML A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity. Journal of neural transmission (Vienna, Austria : 1996) 2008;115(7):1051-62.

Rung, JP; Rung, E; Helgeson, L; Johansson, AM; Svensson, K; Carlsson, A; Carlsson, ML Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization. Journal of neural transmission (Vienna, Austria : 1996) 2008;115(6):899-908.

Osterlund, A; Carlsson, A [Primary health care doesn't follow SFAM's antibiotics prescription goals]. Läkartidningen 2008;105(4):210-4.

Nilsson, M; Hansson, S; Carlsson, A; Carlsson, ML Differential effects of the N-methyl-d-aspartate receptor antagonist MK-801 on different stages of object recognition memory in mice. Neuroscience 2007;149(1):123-30.

Lahti, RA; Tamminga, CA; Carlsson, A Stimulating and inhibitory effects of the dopamine ”stabilizer” (-)-OSU6162 on dopamine D2 receptor function in vitro. Journal of neural transmission (Vienna, Austria : 1996) 2007;114(9):1143-6.

Carlsson, A The neurochemical circuitry of schizophrenia. Pharmacopsychiatry 2006;39 Suppl 1():S10-4.

Tretter, F; Müller, WE; Carlsson, A Identify the specific role of regional changes for the complex symptoms of schizophrenia. Pharmacopsychiatry 2006;39 Suppl 1():S1-2.

Carlsson, A; Carlsson, ML A dopaminergic deficit hypothesis of schizophrenia: the path to discovery. Dialogues in clinical neuroscience 2006;8(1):137-42.

Rung, JP; Carlsson, A; Rydén Markinhuhta, K; Carlsson, ML (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry 2005;29(5):827-32.

Rung, JP; Carlsson, A; Markinhuhta, KR; Carlsson, ML The dopaminergic stabilizers (-)-OSU6162 and ACR16 reverse (+)-MK-801-induced social withdrawal in rats. Progress in neuro-psychopharmacology & biological psychiatry 2005;29(5):833-9.

Lundberg, S; Carlsson, A; Norfeldt, P; Carlsson, ML Nicotine treatment of obsessive-compulsive disorder. Progress in neuro-psychopharmacology & biological psychiatry 2004;28(7):1195-9.

Nilsson, M; Carlsson, A; Markinhuhta, KR; Sonesson, C; Pettersson, F; Gullme, M; Carlsson, ML The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition. Progress in neuro-psychopharmacology & biological psychiatry 2004;28(4):677-85.

Nydén, A; Carlsson, M; Carlsson, A; Gillberg, C Interhemispheric transfer in high-functioning children and adolescents with autism spectrum disorders: a controlled pilot study. Developmental medicine and child neurology 2004;46(7):448-54.

Carlsson, ML; Carlsson, A; Nilsson, M Schizophrenia: from dopamine to glutamate and back. Current medicinal chemistry 2004;11(3):267-77.

Grunder, G; Carlsson, A; Wong, DF Mechanism of new antipsychotic medications: occupancy is not just antagonism. Archives of general psychiatry 2003;60(10):974-7.

Gefvert, O; Lindström, LH; Waters, N; Waters, S; Carlsson, A; Tedroff, J Different corticostriatal patterns of L-DOPA utilization in patients with untreated schizophrenia and patients treated with classical antipsychotics or clozapine. Scandinavian journal of psychology 2003;44(3):289-92.

Carlsson, A Treatment of Parkinson’s with L-DOPA. The early discovery phase, and a comment on current problems. Journal of neural transmission (Vienna, Austria : 1996) 2002;109(5-6):777-87.

Tamminga, CA; Carlsson, A Partial dopamine agonists and dopaminergic stabilizers, in the treatment of psychosis. Current drug targets. CNS and neurological disorders 2002;1(2):141-7.

Haadsma-Svensson, SR; Cleek, KA; Dinh, DM; Duncan, JN; Haber, CL; Huff, RM; Lajiness, ME; Nichols, NF; Smith, MW; Svensson, KA; Zaya, MJ; Carlsson, A; Lin, CH Dopamine D(3) receptor antagonists. 1. Synthesis and structure-activity relationships of 5,6-dimethoxy-N-alkyl- and N-alkylaryl-substituted 2-aminoindans. Journal of medicinal chemistry 2001;44(26):4716-32.

Carlsson, A A half-century of neurotransmitter research: impact on neurology and psychiatry. Nobel lecture. Bioscience reports 2001;21(6):691-710.

Carlsson, A A paradigm shift in brain research. Science (New York, N.Y.) 2001;294(5544):1021-4.

Carlsson, A A half-century of neurotransmitter research: impact on neurology and psychiatry (Nobel lecture). Chembiochem : a European journal of chemical biology 2001;2(7-8):484-93.

Nilsson, M; Waters, S; Waters, N; Carlsson, A; Carlsson, ML A behavioural pattern analysis of hypoglutamatergic mice–effects of four different antipsychotic agents. Journal of neural transmission (Vienna, Austria : 1996) 2001;108(10):1181-96.

Carlsson, A; Waters, N; Holm-Waters, S; Tedroff, J; Nilsson, M; Carlsson, ML Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annual review of pharmacology and toxicology 2001;41():237-60.

Kegeles, LS; Abi-Dargham, A; Zea-Ponce, Y; Rodenhiser-Hill, J; Mann, JJ; Van Heertum, RL; Cooper, TB; Carlsson, A; Laruelle, M Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia. Biological psychiatry 2000;48(7):627-40.

Carlsson, A; Waters, N; Waters, S; Carlsson, ML Network interactions in schizophrenia – therapeutic implications. Brain research. Brain research reviews 2000;31(2-3):342-9.

Carlsson, A; Waters, N; Carlsson, ML Neurotransmitter interactions in schizophrenia–therapeutic implications. Biological psychiatry 1999;46(10):1388-95.

Carlsson, A Birth of neuropsychopharmacology–impact on brain research. Brain research bulletin 1999;50(5-6):363.

Tedroff, J; Ekesbo, A; Sonesson, C; Waters, N; Carlsson, A Long-lasting improvement following (-)-OSU6162 in a patient with Huntington’s disease. Neurology 1999;53(7):1605-6.

Ekesbo, A; Torstenson, R; Hartvig, P; Carlsson, A; Sonesson, C; Waters, N; Tedroff, J; Långström, B Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains. Neuropharmacology 1999;38(3):331-8.

Carlsson, A; Waters, N; Carlsson, ML Neurotransmitter interactions in schizophrenia-therapeutic implications. European archives of psychiatry and clinical neuroscience 1999;249 Suppl 4():37-43.

Carlsson, ML; Martin, P; Nilsson, M; Sorensen, SM; Carlsson, A; Waters, S; Waters, N The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice. Journal of neural transmission (Vienna, Austria : 1996) 1999;106(2):123-9.

Carlsson, A; Hansson, LO; Waters, N; Carlsson, ML A glutamatergic deficiency model of schizophrenia. The British journal of psychiatry. Supplement 1999;(37):2-6.

Tedroff, J; Torstenson, R; Hartvig, P; Sonesson, C; Waters, N; Carlsson, A; Neu, H; Fasth, KJ; Långström, B Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements in subhuman primates: evidence for tone-dependent normalization of striatal dopaminergic activity. Synapse (New York, N.Y.) 1998;28(4):280-7.

Lahti, AC; Weiler, M; Carlsson, A; Tamminga, CA Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia. Journal of neural transmission (Vienna, Austria : 1996) 1998;105(6-7):719-34.

Martin, P; Waters, N; Schmidt, CJ; Carlsson, A; Carlsson, ML Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone. Journal of neural transmission (Vienna, Austria : 1996) 1998;105(4-5):365-96.

Lahti, AC; Weiler, MA; Corey, PK; Lahti, RA; Carlsson, A; Tamminga, CA Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia. Biological psychiatry 1998;43(1):2-11.

Martin, P; Waters, N; Waters, S; Carlsson, A; Carlsson, ML MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride. European journal of pharmacology 1997;335(2-3):107-16.

Neu, H; Hartvig, P; Torstenson, R; Fasth, KJ; Sonesson, C; Waters, N; Carlsson, A; Tedroff, J; Långström, B Synthesis of [11C-methyl]-(-)-OSU6162, its regional brain distribution and some pharmacological effects of (-)-OSU6162 on the dopaminergic system studied in the rhesus monkey by positron emission tomography. Nuclear medicine and biology 1997;24(6):507-11.

Nilsson, M; Carlsson, A; Carlsson, ML Glycine and D-serine decrease MK-801-induced hyperactivity in mice. Journal of neural transmission (Vienna, Austria : 1996) 1997;104(11-12):1195-205.

Carlsson, A; Wong, DT Correction: a note on the discovery of selective serotonin reuptake inhibitors. Life sciences 1997;61(12):1203.

Martin, P; Waters, N; Carlsson, A; Carlsson, ML The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication). Journal of neural transmission (Vienna, Austria : 1996) 1997;104(4-5):561-4.

Carlsson, A; Hansson, LO; Waters, N; Carlsson, ML Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications. Life sciences 1997;61(2):75-94.

Köpf, I; Hultborn, R; Weiss, L; Carlsson, A Vascular cross-sectional area in rat mammary tumours; influence of noradrenaline. Anticancer research 1996;16(3A):1161-4.

Carlsson, A Neurocircuitries and neurotransmitter interactions in schizophrenia. International clinical psychopharmacology 1995;10 Suppl 3():21-8.

Stjernlöf, P; Ennis, MD; Hansson, LO; Hoffman, RL; Ghazal, NB; Sundell, S; Smith, MW; Svensson, K; Carlsson, A; Wikström, H Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. 1. Effects of substituents in the aromatic system on serotonin and dopamine receptor subtypes. Journal of medicinal chemistry 1995;38(12):2202-16.

Kujacic, M; Carlsson, A In vivo activity of tyrosine hydroxylase in rat adrenal glands following administration of quinpirole and dopamine. European journal of pharmacology 1995;278(1):9-15.

Sonesson, C; Barf, T; Nilsson, J; Dijkstra, D; Carlsson, A; Svensson, K; Smith, MW; Martin, IJ; Duncan, JN; King, LJ Synthesis and evaluation of pharmacological and pharmacokinetic properties of monopropyl analogs of 5-, 7-, and 8-[[(trifluoromethyl)sulfonyl]oxy]-2-aminotetralins: central dopamine and serotonin receptor activity. Journal of medicinal chemistry 1995;38(8):1319-29.

Kujacic, M; Hansson, LO; Carlsson, A Acute dopaminergic influence on plasma adrenaline levels in the rat. European journal of pharmacology 1995;273(3):247-57.

Svensson, A; Carlsson, ML; Carlsson, A Crucial role of the accumbens nucleus in the neurotransmitter interactions regulating motor control in mice. Journal of neural transmission. General section 1995;101(1-3):127-48.

Haadsma-Svensson, SR; Smith, MW; Svensson, K; Waters, N; Carlsson, A The chemical structure of U99194A. Journal of neural transmission. General section 1995;99(1-3):I.

Svensson, A; Carlsson, ML; Carlsson, A Glutamatergic neurons projecting to the nucleus accumbens can affect motor functions in opposite directions depending on the dopaminergic tone. Progress in neuro-psychopharmacology & biological psychiatry 1994;18(7):1203-18.

Svensson, K; Carlsson, A; Huff, RM; Kling-Petersen, T; Waters, N Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. European journal of pharmacology 1994;263(3):235-43.

Stjernlöf, P; Elebring, T; Nilsson, J; Andersson, B; Lagerkvist, S; Svensson, K; Ekman, A; Carlsson, A; Wikström, H 6,7,8,9-Tetrahydro-N,N-di-n-propyl-3H-benzindol-8-amines. Derivatives as potent and orally active serotonin 5-HT1A receptor agonists. Journal of medicinal chemistry 1994;37(20):3263-73.

Kujacic, M; Carlsson, A Effects of MPP+ on catecholamine levels in adrenal glands and heart of rats. Naunyn-Schmiedeberg’s archives of pharmacology 1994;350(3):245-51.

Sonesson, C; Lin, CH; Hansson, L; Waters, N; Svensson, K; Carlsson, A; Smith, MW; Wikström, H Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure-activity relationships. Journal of medicinal chemistry 1994;37(17):2735-53.

Kujacic, M; Carlsson, A Influence of GBR 12909 and d-amphetamine on indices of catecholamine synthesis and release in rat adrenal glands. Neuropharmacology 1994;33(8):983-7.

Waters, N; Hansson, L; Löfberg, L; Carlsson, A Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo. European journal of pharmacology 1994;251(2-3):181-90.

Kujacic, M; Carlsson, A I. c. v. dopamine fails to alter adrenomedullary function in rats. Journal of neural transmission. General section 1994;95(3):235-40.

Carlsson, ML; Engberg, G; Carlsson, A Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice. Journal of neural transmission. General section 1994;95(3):223-33.

Martin, P; Svensson, A; Carlsson, A; Carlsson, ML On the roles of dopamine D-1 vs. D-2 receptors for the hyperactivity response elicited by MK-801. Journal of neural transmission. General section 1994;95(2):113-21.

Svensson, K; Carlsson, A; Waters, N Locomotor inhibition by the D3 ligand R-(+)-7-OH-DPAT is independent of changes in dopamine release. Journal of neural transmission. General section 1994;95(1):71-4.

Hansson, LO; Waters, N; Winblad, B; Gottfries, CG; Carlsson, A Evidence for biochemical heterogeneity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortal brain tissue. Journal of neural transmission. General section 1994;98(3):217-35.

Waters, N; Löfberg, L; Haadsma-Svensson, S; Svensson, K; Sonesson, C; Carlsson, A Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour. Journal of neural transmission. General section 1994;98(1):39-55.

Sonesson, C; Boije, M; Svensson, K; Ekman, A; Carlsson, A; Romero, AG; Martin, IJ; Duncan, JN; King, LJ; Wikström, H Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo. Journal of medicinal chemistry 1993;36(22):3409-16.

Sonesson, C; Waters, N; Svensson, K; Carlsson, A; Smith, MW; Piercey, MF; Meier, E; Wikström, H Substituted 3-phenylpiperidines: new centrally acting dopamine autoreceptor antagonists. Journal of medicinal chemistry 1993;36(21):3188-96.

Svensson, K; Eriksson, E; Carlsson, A Partial dopamine receptor agonists reverse behavioral, biochemical and neuroendocrine effects of neuroleptics in the rat: potential treatment of extrapyramidal side effects. Neuropharmacology 1993;32(10):1037-45.

Waters, N; Lagerkvist, S; Löfberg, L; Piercey, M; Carlsson, A The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study. European journal of pharmacology 1993;242(2):151-63.

Lin, CH; Haadsma-Svensson, SR; Phillips, G; McCall, RB; Piercey, MF; Smith, MW; Svensson, K; Carlsson, A; Chidester, CG; Von Voigtlander, PF Synthesis and biological activity of cis-(3aR)-(-)-2,3,3a,4,5,9b-hexahydro- 3-propyl-1H-benz[e]indole-9-carboxamide: a potent and selective 5-HT1A receptor agonist with good oral availability. Journal of medicinal chemistry 1993;36(15):2208-18.

Stjernlöf, P; Gullme, M; Elebring, T; Andersson, B; Wikström, H; Lagerquist, S; Svensson, K; Ekman, A; Carlsson, A; Sundell, S (S)- and (R)-8-(di-n-propylamino)-6,7,8,9-tetrahydro-3H-benz[e]indole-1- carbaldehyde: a new class of orally active 5-HT1A-receptor agonists. Journal of medicinal chemistry 1993;36(15):2059-65.

Waters, N; Svensson, K; Haadsma-Svensson, SR; Smith, MW; Carlsson, A The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. Journal of neural transmission. General section 1993;94(1):11-9.

Kujacic, M; Carlsson, A Evidence for an increased catecholamine synthesis in rat adrenal glands following stimulation of peripheral dopamine receptors. Journal of neural transmission. General section 1993;92(2-3):73-9.

Carlsson, A Thirty years of dopamine research. Advances in neurology 1993;60():1-10.

Carlsson, A On the neuronal circuitries and neurotransmitters involved in the control of locomotor activity. Journal of neural transmission. Supplementum 1993;40():1-12.

Wikström, H; Andersson, B; Elebring, T; Lagerkvist, S; Hallnemo, G; Pettersson, I; Jovall, PA; Svensson, K; Ekman, A; Carlsson, A 6-Hydroxy-3-n-propyl-2,3,4,5-tetrahydro-1H-3-benzazepine and analogs: new centrally acting 5-HT1A receptor agonists. Journal of medicinal chemistry 1992;35(22):3984-90.

Carlsson, A; Jonsson, Y; Svensson, K; Stahl, B; Twetman, S Pit and fissure sealing and mutans streptococci levels in saliva. American journal of dentistry 1992;5(5):280-2.

Piercey, MF; Lum, JT; Hoffmann, WE; Carlsson, A; Ljung, E; Svensson, K Antagonism of cocaine’s pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232. Brain research 1992;588(2):217-22.

Carlsson, A Interaction between dopaminergic and serotonergic systems. Clinical neuropharmacology 1992;15 Suppl 1 Pt A():616A-617A.

Svensson, A; Carlsson, A; Carlsson, ML Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice. Journal of neural transmission. General section 1992;90(3):199-217.

Svensson, A; Carlsson, ML; Carlsson, A Interaction between glutamatergic and dopaminergic tone in the nucleus accumbens of mice: evidence for a dual glutamatergic function with respect to psychomotor control. Journal of neural transmission. General section 1992;88(3):235-40.

Tamminga, CA; Cascella, NG; Lahti, RA; Lindberg, M; Carlsson, A Pharmacologic properties of (-)-3PPP (preclamol) in man. Journal of neural transmission. General section 1992;88(3):165-75.

Carlsson, A Future directions in antipsychotic drug research. Clinical neuropharmacology 1992;15 Suppl 1 Pt A():271A-272A.

Carlsson, A Fifteen years of continued research in psychopharmacology. Pharmacopsychiatry 1992;25(1):22-4.

Kullingsjö, H; Carlsson, A; Svensson, K Effects of repeated administration of the preferential dopamine autoreceptor antagonist, (+)-AJ76, on locomotor activity and brain DA metabolism in the rat. European journal of pharmacology 1991;205(3):241-6.

Svensson, K; Ekman, A; Piercey, MF; Hoffmann, WE; Lum, JT; Carlsson, A Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study. Naunyn-Schmiedeberg’s archives of pharmacology 1991;344(3):263-74.

Carlsson, M; Svensson, A; Carlsson, A Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice. Naunyn-Schmiedeberg’s archives of pharmacology 1991;343(6):568-73.

Carlsson, A; Fornstedt, B Catechol metabolites in the cerebrospinal fluid as possible markers in the early diagnosis of Parkinson’s disease. Neurology 1991;41(5 Suppl 2):50-1; discussion 52.

Fornstedt, B; Carlsson, A Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig. Neuropharmacology 1991;30(5):463-8.

Wallin, A; Carlsson, A; Ekman, R; Gottfries, CG; Karlsson, I; Svennerholm, L; Widerlöv, E Hypothalamic monoamines and neuropeptides in dementia. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1991;1(2):165-8.

Fornstedt, B; Carlsson, A Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea pig striatum. Journal of neurochemistry 1991;56(2):407-14.

Svensson, A; Carlsson, M; Carlsson, A Synergistic interactions between the NMDA antagonist dizocilpine and the preferential dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 with regard to locomotor stimulation in monoamine-depleted mice. Journal of neural transmission. General section 1991;85(1):69-77.

Carlsson, A; Fornstedt, B Possible mechanisms underlying the special vulnerability of dopaminergic neurons. Acta neurologica Scandinavica. Supplementum 1991;136():16-8.

Kujacic, M; Svensson, K; Löfberg, L; Carlsson, A Dopamine receptors, controlling dopamine levels in rat adrenal glands-comparison with central dopaminergic autoreceptors. Journal of neural transmission. General section 1991;84(3):195-209.

Carlsson, A [Monoamine research--a productive field of particular importance in neuroscience]. Läkartidningen 1990;87(45):3764, 3767-9.

Waters, N; Löfberg, L; Svensson, K; Carlsson, A Increased dopamine release by the autoreceptor antagonist (+)-AJ 76 is Ca2(+)-dependent. European journal of pharmacology 1990;187(3):425-34.

Johansson, AM; Fredriksson, K; Hacksell, U; Grol, CJ; Svensson, K; Carlsson, A; Sundell, S Synthesis and pharmacology of the enantiomers of cis-7-hydroxy-3-methyl-2-(dipropylamino)tetralin. Journal of medicinal chemistry 1990;33(10):2925-9.

Fornstedt, B; Pileblad, E; Carlsson, A In vivo autoxidation of dopamine in guinea pig striatum increases with age. Journal of neurochemistry 1990;55(2):655-9.

Carlsson, M; Carlsson, A Interactions between glutamatergic and monoaminergic systems within the basal ganglia–implications for schizophrenia and Parkinson’s disease. Trends in neurosciences 1990;13(7):272-6.

Carlsson, A Schizophrenia: a neurotransmitter imbalance syndrome? Yakubutsu, seishin, kodo = Japanese journal of psychopharmacology 1990;10(1):35-42.

Liljefors, T; Bøgesø, KP; Hyttel, J; Wikström, H; Svensson, K; Carlsson, A Pre- and postsynaptic dopaminergic activities of indolizidine and quinolizidine derivatives of 3-(3-hydroxyphenyl)-N-(n-propyl)piperidine (3-PPP). Further developments of a dopamine receptor model. Journal of medicinal chemistry 1990;33(3):1015-22.

Kujacic, M; Svensson, K; Löfberg, L; Carlsson, A Acute changes in dopamine levels in rat adrenal glands after administration of dopamine receptor agonists and antagonists. European journal of pharmacology 1990;177(3):163-70.

Fornstedt, B; Bergh, I; Rosengren, E; Carlsson, A An improved HPLC-electrochemical detection method for measuring brain levels of 5-S-cysteinyldopamine, 5-S-cysteinyl-3,4-dihydroxyphenylalanine, and 5-S-cysteinyl-3,4-dihydroxyphenylacetic acid. Journal of neurochemistry 1990;54(2):578-86.

Allard, P; Alafuzoff, I; Carlsson, A; Eriksson, K; Ericson, E; Gottfries, CG; Marcusson, JO Loss of dopamine uptake sites labeled with [3H]GBR-12935 in Alzheimer’s disease. European neurology 1990;30(4):181-5.

Carlsson, M; Carlsson, A Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophrenia bulletin 1990;16(3):425-32.

Wikström, H; Andersson, B; Svensson, A; Humber, LG; Asselin, AA; Svensson, K; Ekman, A; Carlsson, A; Nilsson, I; Chidester, C Resolved 6,7,8,9-tetrahydro-N,N-dimethyl-3H-benz[e]indol-8-amine: central dopamine and serotonin receptor stimulating properties. Journal of medicinal chemistry 1989;32(10):2273-6.

Waters, N; Pettersson, G; Carlsson, A; Svensson, K The putatively antipsychotic agent amperozide produces behavioural stimulation in the rat. A behavioural and biochemical characterization. Naunyn-Schmiedeberg’s archives of pharmacology 1989;340(2):161-9.

Wallin, A; Alafuzoff, I; Carlsson, A; Eckernäs, SA; Gottfries, CG; Karlsson, I; Svennerholm, L; Winblad, B Neurotransmitter deficits in a non-multi-infarct category of vascular dementia. Acta neurologica Scandinavica 1989;79(5):397-406.

Nissbrandt, H; Sundström, E; Jonsson, G; Hjorth, S; Carlsson, A Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum. Journal of neurochemistry 1989;52(4):1170-82.

Fornstedt, B; Brun, A; Rosengren, E; Carlsson, A The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra. Journal of neural transmission. Parkinson’s disease and dementia section 1989;1(4):279-95.

Carlsson, M; Carlsson, A Marked locomotor stimulation in monoamine-depleted mice following treatment with atropine in combination with clonidine. Journal of neural transmission. Parkinson’s disease and dementia section 1989;1(4):317-22.

Carlsson, M; Carlsson, A Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice. Journal of neural transmission 1989;77(1):65-71.

Carlsson, M; Carlsson, A The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. Journal of neural transmission 1989;75(3):221-6.

Fornstedt, B; Carlsson, A A marked rise in 5-S-cysteinyl-dopamine levels in guinea-pig striatum following reserpine treatment. Journal of neural transmission 1989;76(2):155-61.

Carlsson, M; Carlsson, A Effects of mild stress on adrenal and heart catecholamines in male and female rats. Journal of neural transmission 1989;77(2-3):217-26.

Carlsson, M; Carlsson, A In vivo evidence for a greater brain tryptophan hydroxylase capacity in female than in male rats. Naunyn-Schmiedeberg’s archives of pharmacology 1988;338(4):345-9.

Carlsson, A The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1988;1(3):179-86.

Snape, BM; Pileblad, E; Ekman, A; Magnusson, T; Carlsson, A; Engel, J The effects of 1-methyl-4-phenylpyridinium ion (MPP+) on the efflux and metabolism of endogenous dopamine in rat striatal slices. The Journal of pharmacy and pharmacology 1988;40(9):620-6.

Hjorth, S; Clark, D; Carlsson, A Dopamine (DA) autoreceptor efficacy of 3-PPP enantiomers after short-term synaptic DA deprivation. European journal of pharmacology 1988;152(3):207-15.

Nissbrandt, H; Engberg, G; Wikström, H; Magnusson, T; Carlsson, A NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors. Naunyn-Schmiedeberg’s archives of pharmacology 1988;338(2):148-61.

Eriksson, T; Granérus, AK; Linde, A; Carlsson, A ’On-off’ phenomenon in Parkinson’s disease: relationship between dopa and other large neutral amino acids in plasma. Neurology 1988;38(8):1245-8.

Wikström, H; Elebring, T; Hallnemo, G; Andersson, B; Svensson, K; Carlsson, A; Rollema, H Occurrence and pharmacological significance of metabolic ortho-hydroxylation of 5- and 8-hydroxy-2-(di-n-propylamino)tetralin. Journal of medicinal chemistry 1988;31(6):1080-4.

Carlsson, A Peptide neurotransmitters–redundant vestiges? Pharmacology & toxicology 1988;62(5):241-2.

Pileblad, E; Carlsson, A Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Pharmacology & toxicology 1988;62(4):213-22.

Arvidsson, LE; Johansson, AM; Hacksell, U; Nilsson, JL; Svensson, K; Hjorth, S; Magnusson, T; Carlsson, A; Lindberg, P; Andersson, B N,N-Dialkylated monophenolic trans-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonists. Journal of medicinal chemistry 1988;31(1):92-9.

Carlsson, A Speculations on the control of mental and motor functions by dopamine-modulated cortico-striato-thalamo-cortical feedback loops. The Mount Sinai journal of medicine, New York 1988;55(1):6-10.

Hajós, M; Engberg, G; Nissbrandt, H; Magnusson, T; Carlsson, A Capsaicin-sensitive vasodilatatory mechanisms in the rat substantia nigra and striatum. Journal of neural transmission 1988;74(3):129-39.

Hajos, M; Hjorth, S; Svensson, K; Carlsson, A In vivo dopamine (DA) receptor binding and behavioural effects of the putative DA autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 in rats with a unilateral nigral 6-OH-DA lesion. Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1988;70(3):577-84.

Carlsson, A Reflections on the history of psychopharmacology. Psychopharmacology series 1988;5():3-11.

Hjorth, S; Carlsson, A In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390. Journal of neural transmission 1988;72(2):83-97.

Eriksson, T; Carlsson, A Beta-adrenergic control of brain uptake of large neutral amino acids. Life sciences 1988;42(17):1583-9.

Carlsson, M; Carlsson, A A regional study of sex differences in rat brain serotonin. Progress in neuro-psychopharmacology & biological psychiatry 1988;12(1):53-61.

Wikström, H; Andersson, B; Elebring, T; Svensson, K; Carlsson, A; Largent, B N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines and 3-phenylpiperidines: effects on central dopamine and sigma receptors. Journal of medicinal chemistry 1987;30(12):2169-74.

Ahlenius, S; Carlsson, A; Hillegaart, V; Hjorth, S; Larsson, K Region-selective activation of brain monoamine synthesis by sexual activity in the male rat. European journal of pharmacology 1987;144(1):77-82.

Arvidsson, LE; Johansson, AM; Hacksell, U; Nilsson, JL; Svensson, K; Hjorth, S; Magnusson, T; Carlsson, A; Andersson, B; Wikström, H (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist. Journal of medicinal chemistry 1987;30(11):2105-9.

Carlsson, M; Carlsson, A; Eriksson, E The intrinsic activities of the partial dopamine receptor agonists (-)-3-PPP and TDHL on pituitary dopamine receptors are lower in female than in male rats. European journal of pharmacology 1987;142(1):39-43.

Johansson, AM; Nilsson, JL; Karlén, A; Hacksell, U; Sanchez, D; Svensson, K; Hjorth, S; Carlsson, A; Sundell, S; Kenne, L C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptors. Journal of medicinal chemistry 1987;30(10):1827-37.

Wikström, H; Andersson, B; Elebring, T; Jacyno, J; Allinger, NL; Svensson, K; Carlsson, A; Sundell, S Resolved cis-10-hydroxy-4-n-propyl-1,2,3,4,4a,5,6,10b- octahydrobenzo[f]quinoline : central serotonin stimulating properties. Journal of medicinal chemistry 1987;30(9):1567-73.

Nissbrandt, H; Carlsson, A Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra. Journal of neurochemistry 1987;49(3):959-67.

Sharp, T; Zetterström, T; Series, HG; Carlsson, A; Grahame-Smith, DG; Ungerstedt, U HPLC-EC analysis of catechols and indoles in rat brain dialysates. Life sciences 1987;41(7):869-72.

Johansson, AM; Nilsson, JL; Karlén, A; Hacksell, U; Svensson, K; Carlsson, A; Kenne, L; Sundell, S C3-methylated 5-hydroxy-2-(dipropylamino)tetralins: conformational and steric parameters of importance for central dopamine receptor activation. Journal of medicinal chemistry 1987;30(7):1135-44.

Johansson, AM; Arvidsson, LE; Hacksell, U; Nilsson, JL; Svensson, K; Carlsson, A Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists. Journal of medicinal chemistry 1987;30(4):602-11.

Hajós, M; Hjorth, S; Carlsson, A Injection of capsaicin into the nucleus raphe dorsalis elicits heat loss in the rat. Neuroscience letters 1987;75(2):199-204.

Svensson, K; Alföldi, P; Hajós, M; Rubicsek, G; Johansson, AM; Carlsson, A; Obál, F Dopamine autoreceptor antagonists: effects on sleep-wake activity in the rat. Pharmacology, biochemistry, and behavior 1987;26(1):123-9.

Carlsson, A Development of new pharmacological approaches in Parkinson’s disease. Advances in neurology 1987;45():513-8.

Hjorth, S; Carlsson, A; Engel, JA Anxiolytic-like action of the 3-PPP enantiomers in the Vogel conflict paradigm. Psychopharmacology 1987;92(3):371-5.

Carlsson, A Perspectives on the discovery of central monoaminergic neurotransmission. Annual review of neuroscience 1987;10():19-40.

Hjorth, S; Carlsson, A Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393. Psychopharmacology 1987;93(4):534-7.

Carlsson, A Brain neurotransmitters in aging and dementia: similar changes across diagnostic dementia groups. Gerontology 1987;33(3-4):159-67.

Pileblad, E; Carlsson, A The Ca++-antagonist nimodipine decreases and the Ca++-agonist Bay K 8644 increases catecholamine synthesis in mouse brain. Neuropharmacology 1987;26(1):101-5.

Svensson, K; Carlsson, M; Carlsson, A; Hjorth, S; Johansson, AM; Eriksson, E The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats. European journal of pharmacology 1986;130(3):237-42.

Svensson, K; Johansson, AM; Magnusson, T; Carlsson, A (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists. Naunyn-Schmiedeberg’s archives of pharmacology 1986;334(3):234-45.

Carlsson, A; Sharp, T; Zetterström, T; Ungerstedt, U Determination of dopamine and its metabolites in small volumes of rat brain dialysates using small-bore liquid chromatography with electrochemical detection. Journal of chromatography 1986;368(2):299-308.

Rollema, H; Mastebroek, D; Wikström, H; Svensson, K; Carlsson, A; Sundell, S Enantiomers of 3-(3,4-dihydroxyphenyl)- and 3-(3-hydroxyphenyl)-N-n-propylpiperidine: central pre- and postsynaptic dopaminergic effects and pharmacokinetics. Journal of medicinal chemistry 1986;29(10):1889-95.

Hjorth, S; Carlsson, A Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors? European journal of pharmacology 1986;129(1-2):131-8.

Carlsson, M; Eriksson, E; Nilsson, C; Carlsson, A Sexually differentiated actions of 3-PPP enantiomers on prolactin secretion. Neuropharmacology 1986;25(8):951-4.

Hjorth, S; Svensson, K; Carlsson, A; Wikström, H; Andersson, B Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP. Naunyn-Schmiedeberg’s archives of pharmacology 1986;333(3):205-18.

Fornstedt, B; Rosengren, E; Carlsson, A Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species. Neuropharmacology 1986;25(4):451-4.

Hjorth, S; Engel, JA; Carlsson, A Anticonflict effects of low doses of the dopamine agonist apomorphine in the rat. Pharmacology, biochemistry, and behavior 1986;24(2):237-40.

Svensson, K; Carlsson, A; Johansson, AM; Arvidsson, LE; Nilsson, JL A homologous series of N-alkylated cis-(+)-(1 S, 2 R)-5-methoxy-1-methyl-2-aminotetralins: central dopamine receptor antagonists showing profiles ranging from classical antagonism to selectivity for autoreceptors. Journal of neural transmission 1986;65(1):29-38.

Gottfries, CG; Bartfai, T; Carlsson, A; Eckernäs, S; Svennerholm, L Multiple biochemical deficits in both gray and white matter of Alzheimer brains. Progress in neuro-psychopharmacology & biological psychiatry 1986;10(3-5):405-13.

Hacksell, U; Arvidsson, LE; Johansson, AM; Nilsson, JL; Sanchez, D; Lindberg, P; Wikström, H; Svensson, K; Hjorth, S; Carlsson, A Indirect central 5-hydroxytryptaminergic actions of methoxy substituted 2-aminotetralin derivatives. Acta pharmaceutica Suecica 1986;23(2):77-90.

Svensson, K; Hjorth, S; Clark, D; Carlsson, A; Wikström, H; Andersson, B; Sanchez, D; Johansson, AM; Arvidsson, LE; Hacksell, U (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on autoreceptors. Journal of neural transmission 1986;65(1):1-27.

Hajós, M; Svensson, K; Nissbrandt, H; Obál, F; Carlsson, A Effects of capsaicin on central monoaminergic mechanisms in the rat. Journal of neural transmission 1986;66(3-4):221-42.

Pileblad, E; Carlsson, A In vivo effects of the Ca2+-antagonist nimodipine on dopamine metabolism in mouse brain. Journal of neural transmission 1986;66(3-4):171-87.

Eriksson, T; Wiesel, K; Carlsson, A Rat brain concentration of administered amino acids: dependence on time of day for administration. Journal of neural transmission 1986;65(1):83-91.

Nissbrandt, H; Pileblad, E; Carlsson, A Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra. The Journal of pharmacy and pharmacology 1985;37(12):884-9.

Hjorth, S; Carlsson, A (-)-Pindolol stereospecifically inhibits rat brain serotonin (5-HT) synthesis. Neuropharmacology 1985;24(11):1143-6.

Röjdmark, S; Carlsson, A Decreased prolactin responsiveness to thyrotrophin-releasing hormone and metoclopramide in hyperthyroidism. Acta endocrinologica 1985;110(2):221-6.

Pileblad, E; Fornstedt, B; Clark, D; Carlsson, A Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatum. The Journal of pharmacy and pharmacology 1985;37(10):707-11.

Hjorth, S; Clark, D; Carlsson, A Lack of functional evidence for the involvement of sigma opiate receptors in the actions of the 3-PPP enantiomers on central dopaminergic systems: discrepancies between in vitro and in vivo observations. Life sciences 1985;37(7):673-84.

Johansson, AM; Arvidsson, LE; Hacksell, U; Nilsson, JL; Svensson, K; Hjorth, S; Clark, D; Carlsson, A; Sanchez, D; Andersson, B Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors. Journal of medicinal chemistry 1985;28(8):1049-53.

Pileblad, E; Carlsson, A Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain. Neuropharmacology 1985;24(7):689-92.

Clark, D; Engberg, G; Pileblad, E; Svensson, TH; Carlsson, A; Freeman, AS; Bunney, BS An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system. Naunyn-Schmiedeberg’s archives of pharmacology 1985;329(4):344-54.

Carlsson, A Neurotransmitter changes in the aging brain. Danish medical bulletin 1985;32 Suppl 1():40-3.

Wikström, H; Andersson, B; Sanchez, D; Lindberg, P; Arvidsson, LE; Johansson, AM; Nilsson, JL; Svensson, K; Hjorth, S; Carlsson, A Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists. Journal of medicinal chemistry 1985;28(2):215-25.

Hjorth, S; Carlsson, A; Clark, D; Svensson, K; Sanchez, D Dopamine receptor-mediated hypothermia induced in rats by (+)-, but not by (-)-3-PPP. European journal of pharmacology 1985;107(3):299-304.

Carlsson, A; Löfberg, L In vivo displacement by 3-PPP enantiomers of N,N-dipropyl-5,6-ADTN from dopamine receptor-binding sites in rat striatum. Journal of neural transmission 1985;64(3-4):173-85.

Hjorth, S; Clark, D; Svensson, K; Carlsson, A; Thorberg, O Sub-chronic administration of (-)-3-PPP and central dopamine receptor sensitivity changes. Journal of neural transmission 1985;64(3-4):187-98.

Clark, D; Hjorth, S; Carlsson, A Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence. Journal of neural transmission 1985;62(1-2):1-52.

Carlsson, A Pharmacological properties of presynaptic dopamine receptor agonists. Psychopharmacology. Supplementum 1985;2():31-8.

Rosengren, E; Linder-Eliasson, E; Carlsson, A Detection of 5-S-cysteinyldopamine in human brain. Journal of neural transmission 1985;63(3-4):247-53.

Clark, D; Hjorth, S; Carlsson, A Dopamine receptor agonists: mechanisms underlying autoreceptor selectivity. II. Theoretical considerations. Journal of neural transmission 1985;62(3-4):171-207.

Carlsson, M; Svensson, K; Eriksson, E; Carlsson, A Rat brain serotonin: biochemical and functional evidence for a sex difference. Journal of neural transmission 1985;63(3-4):297-313.

Clark, D; Hjorth, S; Carlsson, A (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis. European journal of pharmacology 1984;106(1):185-9.

Engel, JA; Hjorth, S; Svensson, K; Carlsson, A; Liljequist, S Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). European journal of pharmacology 1984;105(3-4):365-8.

Engström, A; Engström, P; Tao, ZJ; Carlsson, A; Bennich, H Insect immunity. The primary structure of the antibacterial protein attacin F and its relation to two native attacins from Hyalophora cecropia. The EMBO journal 1984;3(9):2065-70.

Hacksell, U; Johansson, AM; Arvidsson, L; Nilsson, JL; Hjorth, S; Carlsson, A; Wikström, H; Sanchez, D; Lindberg, P C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity. Journal of medicinal chemistry 1984;27(8):1003-7.

Eriksson, T; Magnusson, T; Carlsson, A; Linde, A; Granérus, AK ”On-off” phenomenon in Parkinson’s disease: correlation to the concentration of dopa in plasma. Journal of neural transmission 1984;59(3):229-40.

Arvidsson, LE; Hacksell, U; Johansson, AM; Nilsson, JL; Lindberg, P; Sanchez, D; Wikström, H; Svensson, K; Hjorth, S; Carlsson, A 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists. Journal of medicinal chemistry 1984;27(1):45-51.

Carlsson, A Current theories on the mode of action of antidepressant drugs. Advances in biochemical psychopharmacology 1984;39():213-21.

Larsson, M; Ohman, R; Wallin, L; Wålinder, J; Carlsson, A Antipsychotic treatment with alpha-methyltyrosine in combination with thioridazine: prolactin response and interaction with dopaminergic precursor pools. Journal of neural transmission 1984;60(2):115-32.

Eriksson, T; Carlsson, A; Hagman, M; Jagenburg, R Beta-adrenergic influence on brain concentrations of monoamine precursors. Advances in biochemical psychopharmacology 1984;39():263-70.

Pileblad, E; Nissbrandt, H; Carlsson, A Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (NMPTP) in mouse brain. Journal of neural transmission 1984;60(3-4):199-203.

Eriksson, E; Modigh, K; Carlsson, A; Wikström, H Dopamine receptors involved in prolactin secretion pharmacologically characterized by means of 3-PPP enantiomers. European journal of pharmacology 1983;96(1-2):29-36.

Eriksson, T; Magnusson, T; Carlsson, A; Hagman, M; Jagenburg, R Decrease in plasma amino acids in man after an acute dose of ethanol. Journal of studies on alcohol 1983;44(2):215-21.

Benedetti, MS; Boucher, T; Carlsson, A; Fowler, CJ Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat. Biochemical pharmacology 1983;32(1):47-52.

Häggström, JE; Gunne, LM; Carlsson, A; Wikström, H Antidyskinetic action of 3-PPP, a selective dopaminergic autoreceptor agonist, in Cebus monkeys with persistent neuroleptic-induced dyskinesias. Journal of neural transmission 1983;58(3-4):135-42.

Hjorth, S; Carlsson, A; Clark, D; Svensson, K; Wikström, H; Sanchez, D; Lindberg, P; Hacksell, U; Arvidsson, LE; Johansson, A; Nilsson, JL The search for selective dopaminergic autoreceptor agonists. Journal of neural transmission. Supplementum 1983;18():131-7.

Carlsson, A Dopamine receptor agonists: intrinsic activity vs. state of receptor. Journal of neural transmission 1983;57(4):309-15.

Hjorth, S; Carlsson, A; Clark, D; Svensson, K; Wikström, H; Sanchez, D; Lindberg, P; Hacksell, U; Arvidsson, LE; Johansson, A Central dopamine receptor agonist and antagonist actions of the enantiomers of 3-PPP. Psychopharmacology 1983;81(2):89-99.

Carlsson, A Are ”on-off” effects during chronic L-dopa treatment due to faulty feedback control of the nigrostriatal dopamine pathway? Journal of neural transmission. Supplementum 1983;19():153-61.

Gottfries, CG; Adolfsson, R; Aquilonius, SM; Carlsson, A; Eckernäs, SA; Nordberg, A; Oreland, L; Svennerholm, L; Wiberg, A; Winblad, B Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiology of aging 1983;4(4):261-71.

García-Sevilla, JA; Magnusson, T; Carlsson, A; Folkers, K Substance P: structural requirements for the activation of brain catecholamine synthesis and locomotor activity in rats. Arzneimittel-Forschung 1983;33(9):1249-54.

Clark, D; Carlsson, A; Hjorth, S; Engel, J; Lindberg, P The effect of the enantiomers of 3-PPP on conditioned avoidance responding in the rat. Psychopharmacology 1983;81(1):14-7.

Hjorth, S; Jackson, D; Carlsson, A; Lindberg, P A behavioral study of the changes in the CNS of mice after subchronic treatment with the dopamine autoreceptor agonist 3-PPP. Psychopharmacology bulletin 1982;18(4):149-52.

Hjorth, S; Carlsson, A Buspirone: effects on central monoaminergic transmission–possible relevance to animal experimental and clinical findings. European journal of pharmacology 1982;83(3-4):299-303.

Clark, D; Carlsson, A; Hjorth, S; Svensson, K; Engel, J; Sanchez, D Is 3-PPP a potential antipsychotic agent? Evidence from animal behavioral studies. European journal of pharmacology 1982;83(1-2):131-4.

Wikström, H; Sanchez, D; Lindberg, P; Arvidsson, LE; Hacksell, U; Johansson, A; Nilsson, JL; Hjorth, S; Carlsson, A Monophenolic octahydrobenzo[f]quinolines: central dopamine- and serotonin-receptor stimulating activity. Journal of medicinal chemistry 1982;25(8):925-31.

Carlsson, A Recent observations on new potential and established antidepressant drugs. Pharmacopsychiatria 1982;15(4):116-20.

Nyberg, P; Almay, BG; Carlsson, A; Masters, C; Winblad, B Brain monoamine abnormalities in the two types of Creutzfeldt-Jakob disease. Acta neurologica Scandinavica 1982;66(1):16-24.

Sakabe, T; Dahlgren, N; Carlsson, A; Siesjö, BK Effect of diazepam on cerebral monoamine synthesis during hypoxia and hypercapnia in the rat. Acta physiologica Scandinavica 1982;115(1):57-65.

Eriksson, T; Carlsson, A Adrenergic influence on rat plasma concentrations of tyrosine and tryptophan. Life sciences 1982;30(17):1465-72.

Carlsson, A Exposure to toluene: uptake, distribution and elimination in man. Scandinavian journal of work, environment & health 1982;8(1):43-55.

Eriksson, T; Carlsson, A Isoprenaline increases brain concentrations of administered L-dopa and L-tryptophan in the rat. Psychopharmacology 1982;77(1):98-100.

Jackson, D; Carlsson, A; Hjorth, S; Lindberg, P A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine). Journal of neural transmission 1982;53(4):233-45.

Nyberg, P; Winblad, B; Carlsson, A Monoamine concentrations in the human brain. A comparison between two methods of tissue handling. Journal of neural transmission 1982;54(1-2):85-90.

Hacksell, U; Arvidsson, LE; Svensson, U; Nilsson, JL; Sanchez, D; Wikström, H; Lindberg, P; Hjorth, S; Carlsson, A 3-Phenylpiperidines. Central dopamine-autoreceptor stimulating activity. Journal of medicinal chemistry 1981;24(12):1475-82.

Eriksson, T; Magnusson, T; Carlsson, A; Hagman, M; Jagenburg, R; Edén, S Effects of hypophysectomy, adrenalectomy and (-)-propranolol on ethanol-induced decrease in plasma amino acids. Naunyn-Schmiedeberg’s archives of pharmacology 1981;317(3):214-8.

Ahlenius, S; Larsson, K; Svensson, L; Hjorth, S; Carlsson, A; Lindberg, P; Wikström, H; Sanchez, D; Arvidsson, LE; Hacksell, U; Nilsson, JL Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacology, biochemistry, and behavior 1981;15(5):785-92.

Eriksson, T; Carlsson, A; Hagman, M; Jagenburg, R Effects of pentobarbital and diazepam on rat plasma amino acid patterns. Naunyn-Schmiedeberg’s archives of pharmacology 1981;317(2):165-7.

Arvidsson, LE; Hacksell, U; Nilsson, JL; Hjorth, S; Carlsson, A; Lindberg, P; Sanchez, D; Wikstrom, H 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. Journal of medicinal chemistry 1981;24(8):921-3.

Hacksell, U; Arvidsson, LE; Svensson, U; Nilsson, JL; Wikström, H; Lindberg, P; Sanchez, D; Hjorth, S; Carlsson, A; Paalzow, L Monophenolic 2-(dipropylamino)indans and related compounds: central dopamine-receptor stimulating activity. Journal of medicinal chemistry 1981;24(4):429-34.

Hjorth, S; Carlsson, A; Wikström, H; Lindberg, P; Sanchez, D; Hacksell, U; Arvidsson, LE; Svensson, U; Nilsson, JL 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors. Life sciences 1981;28(11):1225-38.

Carlsson, A; Fowler, CJ; Magnusson, T; Oreland, L; Wiberg, A The activities of monoamine oxidase-A and -B, succinate dehydrogenase and acid phosphatase in the rat brain after hemitransection. Naunyn-Schmiedeberg’s archives of pharmacology 1981;316(1):51-5.

Fowler, CJ; Carlsson, A; Winblad, B Monoamine oxidase-A and -B activities in the brain stem of schizophrenics and non-schizophrenic psychotics. Journal of neural transmission 1981;52(1-2):23-32.

Carlsson, A Some current problems related to the mode of action of antidepressant drugs. Acta psychiatrica Scandinavica. Supplementum 1981;290():63-6.

Eriksson, T; Carlsson, A Ethanol-induced increase in brain concentrations of administered neutral amino acids. Naunyn-Schmiedeberg’s archives of pharmacology 1980;314(1):47-50.

Hjorth, S; Carlsson, A; Lindberg, P A new centrally acting DA-receptor agonist with selectivity for autoreceptors. Psychopharmacology bulletin 1980;16(3):85-90.

Eriksson, T; Carlsson, A; Liljequist, S; Hagman, M; Jagenburg, R Decrease in plasma amino acids in rat after acute administration of ethanol. The Journal of pharmacy and pharmacology 1980;32(7):512-3.

Oreland, L; Fowler, CJ; Carlsson, A; Magnusson, T Monoamine oxidase -A and -B activity in the rat brain after hemitransection. Life sciences 1980;26(2):139-46.

Carlsson, A; Svennerholm, L; Winblad, B Seasonal and circadian monoamine variations in human brains examined post mortem. Acta psychiatrica Scandinavica. Supplementum 1980;280():75-85.

Carlsson, A; Adolfsson, R; Aquilonius, SM; Gottfries, CG; Oreland, L; Svennerholm, L; Winblad, B Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism. Advances in biochemical psychopharmacology 1980;23():295-304.

Muller, P; Svensson, TH; Carlsson, A Pre- and postsynaptic mechanisms in haloperidol-induced sensitization to dopaminergic agonists. Advances in biochemical psychopharmacology 1980;24():69-74.

García-Sevilla, JA; Magnusson, T; Carlsson, A Effects of enkephalins and two enzyme resistant analogues on monoamine synthesis and metabolism in rat brain. Naunyn-Schmiedeberg’s archives of pharmacology 1980;310(3):211-8.

Hacksell, U; Svensson, U; Nilsson, JL; Hjorth, S; Carlsson, A; Wikström, H; Lindenberg, P; Sanchez, D N-Alkylated 2-aminotetralins: central dopamine-receptor stimulating activity. Journal of medicinal chemistry 1979;22(12):1469-75.

Agardh, CD; Carlsson, A; Linqvist, M; Siesjö, BK The effect of pronounced hypoglycemia on monoamine metabolism in rat brain. Diabetes 1979;28(9):804-9.

Eriksson, T; Liljequist, S; Carlsson, A Ethanol-induced increase in the penetration of exogenously administered L-dopa through the blood-brain barrier. The Journal of pharmacy and pharmacology 1979;31(9):636-7.

Ahtee, L; Carlsson, A Dual action of methadone on 5-HT synthesis and metabolism. Naunyn-Schmiedeberg’s archives of pharmacology 1979;307(1):51-6.

Fowler, CJ; Oreland, L; Wiberg, A; Carlsson, A; Magnusson, T The inhibition of rat brain monoamine oxidase-B by J-508 (N-methyl-N-propargyl-(1-indanyl)-ammonium hydrochloride), and its use for the titration of this enzyme form. Medical biology 1979;57(6):406-11.

Garcia-Sevilla, JA; Magnusson, T; Carlsson, A Opposite effects of naloxone on substance P-induced changes in brain DOPA synthesis and in locomotor activity in rats. Journal of neural transmission 1979;45(3):185-93.

Engel, J; Ahlenius, S; Almgren, O; Carlsson, A; Larsson, K; Södersten, P Effects of gonadectomy and hormone replacement on brain monoamine synthesis in male rats. Pharmacology, biochemistry, and behavior 1979;10(1):149-54.

García-Sevilla, JA; Magnusson, T; Carlsson, A; Leban, J; Folkers, K Neurotensin and its amide analogue [Gln4]-neurotensin: effects on brain monoamine turnover. Naunyn-Schmiedeberg’s archives of pharmacology 1978;305(3):213-8.

Calderini, G; Carlsson, A; Nordström, CH Influence of transient ischemia on monoamine metabolism in the rat brain during nitrous oxide and phenobarbitone anaesthesia. Brain research 1978;157(2):303-10.

Calderini, G; Carlsson, A; Nordström, CH Monoamine metabolism during bicuculline-induced epileptic seizures in the rat. Brain research 1978;157(2):295-302.

Liljequist, S; Carlsson, A Alteration of central catecholamine metabolism following acute administration of ethanol. The Journal of pharmacy and pharmacology 1978;30(11):728-30.

Garcia-Sevilla, JA; Magnusson, T; Carlsson, A Effect of intracerebroventricularly administered somatostatin on brain monoamine turnover. Brain research 1978;155(1):159-64.

Garcia-Sevilla, JA; Ahtee, L; Magnusson, T; Carlsson, A Opiate-receptor mediated changes in monoamine synthesis in rat brain. The Journal of pharmacy and pharmacology 1978;30(10):613-21.

Biswas, B; Carlsson, A Effect of intraperitoneally administered GABA on the locomotor activity of mice. Psychopharmacology 1978;59(1):91-4.

Wikström, H; Lindberg, P; Martinson, P; Hjorth, S; Carlsson, A Pivaloyl esters of N,N-dialkylated dopamine congeners. Central dopamine-receptor stimulating activity. Journal of medicinal chemistry 1978;21(9):864-7.

Garcia de Yebenes Prous, J; Carlsson, A; Mena Gomez, MA The effect of taurine on motor behaviour, body temperature and monoamine metabolism in rat brain. Naunyn-Schmiedeberg’s archives of pharmacology 1978;304(2):95-9.

Carlsson, A; Lindqvist, M Dependence of 5-HT and catecholamine synthesis on concentrations of precursor amino-acids in rat brain. Naunyn-Schmiedeberg’s archives of pharmacology 1978;303(2):157-64.

Biswas, B; Carlsson, A Potentiation by neuroleptic agents of the inhibitory action of intraperitoneally administered GABA on the locomotor activity of mice. Pharmacology, biochemistry, and behavior 1978;8(6):651-4.

Biswas, B; Carlsson, A On the mode of action of diazepam on brain catecholamine metabolism. Naunyn-Schmiedeberg’s archives of pharmacology 1978;303(1):73-8.

Carlsson, A; Henning, M; Lindberg, P; Martinson, P; Trolin, G; Waldeck, B; Wickberg, B On the disulfiram-like effect of coprine, the pharmacologically active principle of Coprinus atramentarius. Acta pharmacologica et toxicologica 1978;42(4):292-7.

Carlsson, A Does dopamine have a role in schizophrenia? Biological psychiatry 1978;13(1):3-21.

Carlsson, A Antipsychotic drugs, neurotransmitters, and schizophrenia. The American journal of psychiatry 1978;135(2):165-73.

Carlsson, A Age-dependent changes in central dopaminergic and other monoaminergic systems. Advances in experimental medicine and biology 1978;113():1-13.

Carlsson, A; Lindqvist, M Effects of antidepressant agents on the synthesis of brain monoamines. Journal of neural transmission 1978;43(2):73-91.

Mena Gomez, MA; Carlsson, A; Garcia de Yebenes, J The effect of beta-alanine on motor behaviour, body temperature and cerebral monoamine metabolism in rat. Journal of neural transmission 1978;43(1):1-9.

Garcia de Yebenes Prous, J; Carlsson, A; Mena Gomez, MA The effect of CO2 on monoamine metabolism in rat brain. Naunyn-Schmiedeberg’s archives of pharmacology 1977;301(1):11-5.

Carlsson, A Does dopamine play a role in schizophrenia? Psychological medicine 1977;7(4):583-97.

Ablad, B; Almgren, O; Carlsson, A; Henning, M; Jonasson, J; Ljung, B Reduced adrenal amine synthesis in spontaneously hypertensive rats after long-term treatment with propranolol. British journal of pharmacology 1977;61(2):318-20.

Ohman, R; Larsson, M; Nilsson, IM; Engel, J; Carlsson, A Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain. Naunyn-Schmiedeberg’s archives of pharmacology 1977;299(2):105-14.

Biswas, B; Carlsson, A The effect of intraperitoneally administered GABA on brain monoamine metabolism. Naunyn-Schmiedeberg’s archives of pharmacology 1977;299(1):47-51.

Biswas, B; Carlsson, A The effect of intracerebroventricularly administered GABA on brain monoamine metabolism. Naunyn-Schmiedeberg’s archives of pharmacology 1977;299(1):41-6.

Carlsson, A; Holmin, T; Lindqvist, M; Siesjö, BK Effect of hypercapnia and hypocapnia on tryptophan and tyrosine hydroxylation in rat brain. Acta physiologica Scandinavica 1977;99(4):503-9.

Strömbom, U; Svensson, TH; Carlsson, A Antagonism of ethanol’s central stimulation in mice by small doses of catecholamine-receptor agonists. Psychopharmacology 1977;51(3):293-9.

Kehr, W; Carlsson, A; Lindqvist, M Catecholamine synthesis in rat brain after axotomy: interaction between apomorphine and haloperidol. Naunyn-Schmiedeberg’s archives of pharmacology 1977;297(2):111-7.

Carlsson, A Dopaminergic autoreceptors: background and implications. Advances in biochemical psychopharmacology 1977;16():439-41.

Carlsson, A; Kehr, W; Lindqvist, M Agonist–antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation. Journal of neural transmission 1977;40(2):99-113.

Carlsson, A; Biswas, B; Lindqvist, M Influence of GABA and GABA-like drugs on monoaminergic mechanisms. Advances in biochemical psychopharmacology 1977;16():471-5.

Engel, J; Carlsson, A Catecholamines and behavior. Current developments in psychopharmacology 1977;4():1-32.

Cott, J; Carlsson, A; Engel, J; Lindqvist, M Suppression of ethanol-induced locomotor stimulation by GABA-like drugs. Naunyn-Schmiedeberg’s archives of pharmacology 1976;295(3):203-9.

Carlsson, A; Kehr, W; Lindqvist, M The role of intraneuronal amine levels in the feedback control of dopamine, noradrenaline and 5-hydroxytryptamine synthesis in rat brain. Journal of neural transmission 1976;39(1-2):1-19.

Carlsson, A; Winblad, B Influence of age and time interval between death and autopsy on dopamine and 3-methoxytyramine levels in human basal ganglia. Journal of neural transmission 1976;38(3-4):271-6.

Kehr, W; Lindqvist, M; Carlsson, A Distribution of dopamine in the rat cerebral cortex. Journal of neural transmission 1976;38(3-4):173-80.

Almgren, O; Snider, SR; Carlsson, A Recovery of dopamine in peripheral adrenergic nerves after reserpine treatment. Naunyn-Schmiedeberg’s archives of pharmacology 1976;292(2):133-6.

Carlsson, A Some aspects of dopamine in the basal ganglia. Research publications – Association for Research in Nervous and Mental Disease 1976;55():181-9.

Carlsson, A The contribution of drug research to investigating the nature of endogenous depression. Pharmakopsychiatrie, Neuro-Psychopharmakologie 1976;9(1):2-10.

Magnusson, T; Carlsson, A; Fisher, GH; Chang, D; Folkers, K Effect of synthetic substance P on monoaminergic mechanisms in brain. Journal of neural transmission 1976;38(2):89-93.

Brown, RM; Kehr, W; Carlsson, A Functional and biochemical aspects of catecholamine metabolism in brain under hypoxia. Brain research 1975;85(3):491-509.

Ahlenius, S; Carlsson, A; Engel, J Antagonism by baclophen of the d-amphetamine-induced disruption of a successive discrimination in the rat. Journal of neural transmission 1975;36(3-4):327-33.

Kehr, W; Carlsson, A; Lindqvist, M Biochemical aspects of dopamine agonists. Advances in neurology 1975;9():185-95.

Lindqvist, M; Kehr, W; Carlsson, A Attempts to measure endogenous levels of dopa and 5-hydroxytryptophan in rat brain. Journal of neural transmission 1975;36(3-4):161-76.

Carlsson, A Drugs acting through dopamine release. Pharmacology & therapeutics. Part B: General & systematic pharmacology 1975;1(3):401-5.

Carlsson, A Monoamine-depleting drugs. Pharmacology & therapeutics. Part B: General & systematic pharmacology 1975;1(3):393-400.

Carlsson, A Monoamine precursors and analogues. Pharmacology & therapeutics. Part B: General & systematic pharmacology 1975;1(3):381-92.

Waldeck, B; Snider, SR; Brown, R; Carlsson, A Studies on the synthesis and subcellular distribution of dopamine in the rat adrenal medulla. Naunyn-Schmiedeberg’s archives of pharmacology 1975;287(1):1-10.

Carlsson, A; Kehr, W; Lindguist, M Proceedings: Short-term control of tyrosine hydroxylase. Psychopharmacology bulletin 1974;10(3):28.

Brown, RM; Snider, SR; Carlsson, A Changes in biogenic amine synthesis and turnover induced by hypoxia and/or foot shock stress. II. The central nervous system. Journal of neural transmission 1974;35(4):293-305.

Snider, SR; Brown, RM; Carlsson, A Changes in biogenic amine synthesis and turnover induced by hypoxia and/or foot shock stress. I. The adrenal medulla. Journal of neural transmission 1974;35(4):283-91.

Carlsson, A; Lindqvist, M; Kehr, W Postmortal accumulation of 3-methoxytyramine in brain. Naunyn-Schmiedeberg’s archives of pharmacology 1974;284(4):365-72.

Lindqvist, M; Kehr, W; Carlsson, A Effect of pentobarbitone and diethyl ether on the synthesis of monoamines in rat brain. Naunyn-Schmiedeberg’s archives of pharmacology 1974;284(3):263-77.

Carlsson, A; Engel, J; Strömbom, U; Svensson, TH; Waldeck, B Suppression by dopamine-agonists of the ethanol-induced stimulation of locomotor activity and brain dopamine synthesis. Naunyn-Schmiedeberg’s archives of pharmacology 1974;283(2):117-28.

Carlsson, A Antipsychotic drugs and catecholamine synapses. Journal of psychiatric research 1974;11():57-64.

Carlsson, A Some aspects of dopamine in the central nervous system. Advances in neurology 1974;5():59-68.

Carlsson, A; Lindqvist, M Studies on the neurogenic short-term control of adrenomedullary hormone synthesis. Journal of neural transmission 1974;35(3):181-96.

Carlsson, A; Kehr, W; Lindqvist, M Short-term control of tyrosine hydroxylase. Advances in biochemical psychopharmacology 1974;12(0):135-42.

Carlsson, A Measurements of monoamine synthesis and turnover with special reference to 5-hydroxytryptamine. Advances in biochemical psychopharmacology 1974;10():75-81.

Davis, JN; Carlsson, A; MacMillan, V; Siesjö, BK Brain tryptophan hydroxylation: dependence on arterial oxygen tension. Science (New York, N.Y.) 1973;182(107):72-4.

Davis, JN; Carlsson, A The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain. Journal of neurochemistry 1973;21(4):783-90.

Ahlenius, S; Carlsson, A; Engel, J; Svensson, T; Södersten, P Antagonism by alpha methyltyrosine of the ethanol-induced stimulation and euphoria in man. Clinical pharmacology and therapeutics 1973;14(4):586-91.

Carlsson, A [Mode of action of tricyclic antidepressants]. Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1973;93(17):1300-2.

Carlsson, A [Theories on the models of action of antipsychotic drugs]. Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1973;93(17):1298-300.

Carlsson, A; Lindqvist, M Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo. The Journal of pharmacy and pharmacology 1973;25(6):437-40.

Brown, R; David, JN; Carlsson, A Dopa reversal of hypoxia-induced disruption of the conditioned avoidance response. The Journal of pharmacy and pharmacology 1973;25(5):412-4.

Davis, JN; Carlsson, A Effect of hypoxia on tyrosine and tryptophan hydroxylation in unanaesthetized rat brain. Journal of neurochemistry 1973;20(3):913-5.

Carlsson, A; Magnusson, T; Svensson, TH; Waldeck, B Effect of ethanol on the metabolism of brain catecholamines. Psychopharmacologia 1973;30(1):27-36.

Carlsson, A; Lindqvist, M; Magnusson, T; Atack, C Effect of acute transection on the synthesis and turnover of 5-HT in the rat spinal cord. Naunyn-Schmiedeberg’s archives of pharmacology 1973;277(1):1-12.

Carlsson, A; Lindqvist, M In-vivo measurements of tryptophan and tyrosine hydroxylase activities in mouse brain. Journal of neural transmission 1973;34(2):79-91.

Snider, SR; Almgren, O; Carlsson, A The occurrence and functional significance of dopamine in some peripheral adrenergic nerves of the rat. Naunyn-Schmiedeberg’s archives of pharmacology 1973;278(1):1-12.

Atack, C; Carlsson, A In vitro release of endogenous histamine, together with noradrenaline and 5-hydroxytryptamine, from slices of mouse cerebral hemispheres. The Journal of pharmacy and pharmacology 1972;24(12):990-2.

Kehr, W; Carlsson, A; Lindqvist, M; Magnusson, T; Atack, C Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. The Journal of pharmacy and pharmacology 1972;24(9):744-7.

Carlsson, A; Bédard, P; Lindqvist, M; Magnusson, T The influence of nerve-impulse flow on the synthesis and metabolism of hydroxytryptamine. The Biochemical journal 1972;128(3):70P-71P.

Carlsson, A; Kehr, W; Lindqvist, M; Magnusson, T; Atack, CV Regulation of monoamine metabolism in the central nervous system. Pharmacological reviews 1972;24(2):371-84.

Carlsson, A; Davis, JN; Kehr, W; Lindqvist, M; Atack, CV Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg’s archives of pharmacology 1972;275(2):153-68.

Carlsson, A; Engel, J; Svensson, TH Inhibition of ethanol-induced excitation in mice and rats by -methyl-p-tyrosine. Psychopharmacologia 1972;26(3):307-12.

Carlsson, A; Bédard, P; Lindqvist, M; Magnusson, T The influence of nerve-impulse flow on the synthesis and metabolism of 5-hydroxytryptamine in the central nervous system. Biochemical Society symposium 1972;(36):17-32.

Carlsson, A Biochemical and pharmacological aspects of Parkinsonism. Acta neurologica Scandinavica. Supplementum 1972;51():11-42.

Carlsson, A; Lindqvist, M The effect of L-tryptophan and some psychotropic drugs on the formation of 5-hydroxytryptophan in the mouse brain in vivo. Journal of neural transmission 1972;33(1):23-43.

Kehr, W; Carlsson, A; Lindqvist, M A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain. Naunyn-Schmiedeberg’s archives of pharmacology 1972;274(3):273-80.

Carlsson, A; Waldeck, B Formation of dopamine from 3-methoxytyrosine. Fact or artifact? Naunyn-Schmiedeberg’s archives of pharmacology 1972;272(4):441-6.

Bergmark, J; Carlsson, A; Granerus, AK; Jagenburg, R; Magnusson, T; Svanborg, A Decarboxylation of orally administered L-dopa in the human digestive tract. Naunyn-Schmiedeberg’s archives of pharmacology 1972;272(4):437-40.

Bédard, P; Carlsson, A; Lindqvist, M Effect of a transverse cerebral hemisection on 5-hydroxytryptamine metabolism in the rat brain. Naunyn-Schmiedeberg’s archives of pharmacology 1972;272(1):1-15.

Snider, SR; Carlsson, A The adrenal dopamine as an indicator of adrenomedullary hormone biosynthesis. Naunyn-Schmiedeberg’s archives of pharmacology 1972;275(4):347-57.

Meek, JL; Fuxe, K; Carlsson, A Blockade of p-chloromethamphetamine induced 5-hydroxytryptamine depletion by chlorimipramine, chlorpheniramine and meperidine. Biochemical pharmacology 1971;20(3):707-9.

Carlsson, A Basic concepts underlying recent developments in the field of Parkinson’s disease. Contemporary neurology series 1971;8():1-31.

Bédard, P; Carlsson, A; Fuxe, K; Lindqvist, M Origin of 5-hydroxytryptophan and l-dopa accumulating in brain following decarboxylase inhibition. Naunyn-Schmiedebergs Archiv für Pharmakologie 1971;269(1):1-6.

Carlsson, A Structural specificity for inhibition of [14C]-5-hydroxytryptamine uptake by cerebral slices. The Journal of pharmacy and pharmacology 1970;22(10):729-32.

Carlsson, A; Lindqvist, M Accumulation of 5-hydroxytryptophan in mouse brain after decarboxylase inhibition. The Journal of pharmacy and pharmacology 1970;22(9):726-7.

Carlsson, A; Lindqvist, M; Wysokowski, J; Corrodi, H; Junggren, U Substituted metatyramines as brain monoamine depletors. Acta pharmaceutica Suecica 1970;7(3):293-302.

Andén, NE; Carlsson, A; Kerstell, J; Magnusson, T; Olsson, R; Roos, BE; Steen, B; Steg, G; Svanborg, A; Thieme, G; Werdinius, B Oral L-dopa treatment of parkinsonism. Acta medica Scandinavica 1970;187(4):247-55.

Carlsson, A; Jonason, J; Lindqvist, M On the mechanism of 5-hydroxytryptamine release by thymoleptics. The Journal of pharmacy and pharmacology 1969;21(11):769-73.

Carlsson, A; Lindqvist, M Central and peripheral monoaminergic membrane-pump blockade by some addictive analgesics and antihistamines. The Journal of pharmacy and pharmacology 1969;21(7):460-4.

Carlsson, A; Fuxe, K; Hamberger, B; Malmfors, T Effect of a new series of bicyclic compounds with potential thymoleptic properties on the reserpine-resistant uptake mechanism of central and peripheral monoamine neurones in vivo and in vitro. British journal of pharmacology 1969;36(1):18-28.

Carlsson, A; Corrodi, H; Fuxe, K; Hökfelt, T Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. European journal of pharmacology 1969;5(4):367-73.

Carlsson, A; Corrodi, H; Fuxe, K; Hökfelt, T Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. European journal of pharmacology 1969;5(4):357-66.

Carlsson, A; Jonason, J; Lindqvist, M; Fuxe, K Demonstration of extraneuronal 5-hydroxytryptamine accumulation in brain following membrane-pump blockade by chlorimipramine. Brain research 1969;12(2):456-60.

Carlsson, A Pseudo-transmitters. Journal of neuro-visceral relations 1969;31():Suppl 9:249+.

Carlsson, A Pharmacology of synaptic monoamine transmission. Progress in brain research 1969;31():53-9.

Andén, NE; Carlsson, A; Häggendal, J Adrenergic mechanisms. Annual review of pharmacology 1969;9():119-34.

Carlsson, A; Meisch, JJ; Waldeck, B On the beta-hydroxylation of (+-)-alpha-methyldopamine in vivo. European journal of pharmacology 1968;5(1):85-92.

Carlsson, A; Waldeck, B Different mechanisms of drug-induced release of noradrenaline and its congeners alpha-methylnoradrenaline and metaraminol. European journal of pharmacology 1968;4(2):165-8.

Carlsson, A; Lindqvist, M; Waldeck, B Mechanism of release of alpha-methylated noradrenaline analogues by monoamine oxidase inhibitors. European journal of pharmacology 1968;3(1):34-9.

Carlsson, A; Fuxe, K; Ungerstedt, U The effect of imipramine on central 5-hydroxytryptamine neurons. The Journal of pharmacy and pharmacology 1968;20(2):150-1.

Carlsson, A; Waldeck, B Release of alpha-methylated noradrenaline analogues by nialamide. Acta pharmacologica et toxicologica 1968;26(6):501-6.

Carlsson, A; Fuxe, K; Hökfelt, T Effect of desmethylimipramine, protriptyline and (+)-amphetamine on fluorescence of central adrenergic neurons of rats pretreated with alpha-methyl-DOPA and tetrabenazine or reserpine. European journal of pharmacology 1967;2(3):196-201.

Carlsson, A; Lindqvist, M Metatyrosine as a tool for selective protection of catecholamine stores against reserpine. European journal of pharmacology 1967;2(3):187-92.

Carlsson, A; Lundborg, P; Stitzel, R; Waldeck, B Uptake, storage and release of H3-alpha-methyl norepinephrine. The Journal of pharmacology and experimental therapeutics 1967;158(2):175-82.

Carlsson, A Selective protection of 5-hydroxytryptamine stores against the action of reserpine by treatment with 5-hydroxytryptophan. The Journal of pharmacy and pharmacology 1967;19(11):783-4.

Carlsson, A Neurohumoral transmission and neuropsychiatric disorders. International journal of psychiatry 1967;4(3):218-9.

Carlsson, A; Fuxe, K; Hökfelt, T Failure of dopamine to accumulate in central noradrenaline neurons after depletion with diethyldithiocarbamate. The Journal of pharmacy and pharmacology 1967;19(7):481-3.

Carlsson, A; Waldeck, B The accumulation of [3H]noradrenaline in the adrenergic nerve fibres of reserpine-treated mice. The Journal of pharmacy and pharmacology 1967;19(3):182-90.

Meisch, JJ; Carlsson, A; Waldeck, B Effect of desipramine and reserpine on the in vivo beta-hydroxylation of alpha-methyl-m-tyramine and alpha-methyldopamine. The Journal of pharmacy and pharmacology 1967;19(1):63-5.

Carlsson, A Recent studies on the mode of action of antidepressive drugs. Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 1967;257(1):115-7.

Carlsson, A; Fuxe, K; Hamberger, B; Lindqvist, M Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons. Acta physiologica Scandinavica 1966;67(3):481-97.

Carlsson, A; Waldeck, B Release of 3H-metaraminol by different mechanisms. Acta physiologica Scandinavica 1966;67(3):471-80.

Carlsson, A; Waldeck, B Effects of amphetamine, tyramine, and protriptyline on reserpine-resistant amine-concentrating mechanisms of adrenergic nerves. The Journal of pharmacy and pharmacology 1966;18(4):252-3.

Carlsson, A; Lindqvist, M; Fuxe, K; Hamberger, B The effect of (+)-amphetamine on various central and peripheral catecholamine-containing neurones. The Journal of pharmacy and pharmacology 1966;18(2):128-30.

Carlsson, A; Lindqvist, M The interference of tetrabenazine, benzquinamide and prenylamine with the action of reserpine. Acta pharmacologica et toxicologica 1966;24(2):112-20.

Carlsson, A; Waldeck, B Structure-activity relationships for release of 14C-octopamine from adrenergic nerves by phenylethylamines. Acta pharmacologica et toxicologica 1966;24(2):255-62.

Carlsson, A; Lindqvist, M; Fuxe, K; Hökfelt, T Histochemical amd biochemical effects of diethyldithiocarbamate on tissue catecholamines. The Journal of pharmacy and pharmacology 1966;18(1):60-2.

Trcka, V; Carlsson, A Mediodespidine, hypotensive reserpoid without sedative effect. II. Effect on monoamine levels in mouse organs. Life sciences 1965;4(23):2263-7.

CARLSSON, A; THEORELL, H [THE ANDERS JAHRE MEDICAL PRIZE 1965]. Nordisk medicin 1965;74():785-7.

Carlsson, A; Lindqvist, M; Dahlström, A; Fuxe, K; Masuoka, D Effects of the amphetamine group on intraneuronal brain amines in vivo and in vitro. The Journal of pharmacy and pharmacology 1965;17(8):521-3.

Carlsson, A [The mechanism of action of neuroleptics and antidepressive drugs]. Läkartidningen 1965;62(25):1978-90.

Carlsson, A; Waldeck, B Rapid release of 3H-metaraminol induced by combined treatment with protriptyline and reserpine. The Journal of pharmacy and pharmacology 1965;17(5):327-8.

CARLSSON, A; DAHLSTROEM, A; FUXE, K; LINDQVIST, M HISTOCHEMICAL AND BIOCHEMICAL DETECTION OF MONOAMINE RELEASE FROM BRAIN NEURONS. Life sciences 1965;4():809-16.

CARLSSON, A; WALDECK, B INHIBITION OF 3H-METARAMINOL UPTAKE BY ANTIDEPRESSIVE AND RELATED AGENTS. The Journal of pharmacy and pharmacology 1965;17():243-4.

CARLSSON, A; WALDECK, B MECHANISM OF AMINE TRANSPORT IN THE CELL MEMBRANES OF THE ADRENERGIC NERVES. Acta pharmacologica et toxicologica 1965;22():293-300.

CARLSSON, A; DAHLSTROEM, A; FUXE, K; HILLARP, NA FAILURE OF RESERPINE TO DEPLETE NORADRENALINE NEURONS OF ALPHA-METHYLNORADRENALINE FORMED FROM ALPHA-METHYL DOPA. Acta pharmacologica et toxicologica 1965;22():270-6.

ANDEN, NE; CARLSSON, A; HILLARP, NA; MAGNUSSON, T NORADRENALINE RELEASE BY NERVE STIMULATION OF THE SPINAL CORD. Life sciences 1965;4():129-32.

Utley, JD; Carlsson, A Relative effects of L-DOPA and its methyl ester given orally or intraperitoneally to reserpine-treated mice. Acta pharmacologica et toxicologica 1965;23(2):189-93.

CARLSSON, A; FOLKOW, B; HAEGGENDAL, J SOME FACTORS INFLUENCING THE RELEASE OF NORADRENALINE INTO THE BLOOD FOLLOWING SYMPATHETIC STIMULATION. Life sciences 1964;3():1335-41.

CARLSSON, A EVIDENCE FOR A ROLE OF DOPAMINE IN EXTRAPYRAMIDAL FUNCTIONS. Acta neurovegetativa 1964;26():484-93.

ANDEN, NE; CARLSSON, A; DAHLSTROEM, A; FUXE, K; HILLARP, NA; LARSSON, K DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS. Life sciences 1964;3():523-30.

ANDEN, NE; CARLSSON, A; HILLARP, NA; MAGNUSSON, T 5-HYDROXYTRYPTAMINE RELEASE BY NERVE STIMULATION OF THE SPINAL CORD. Life sciences 1964;3():473-8.

SEIDEN, LS; CARLSSON, A BRAIN AND HEART CATECHOLAMINE LEVELS AFTER L-DOPA ADMINISTRATION IN RESERPINE TREATED MICE: CORRELATIONS WITH A CONDITIONED AVOIDANCE RESPONSE. Psychopharmacologia 1964;5():178-81.

ANDEN, NE; CARLSSON, A; HILLARP, NA INHIBITION BY 5-HYDROXYTRYPTOPHAN OF INSULIN-INDUCED ADRENALINE DEPLETION. Acta pharmacologica et toxicologica 1964;21():183-6.

CARLSSON, A; WALDECK, B A METHOD FOR THE FLUORIMETRIC DETERMINATION OF 3-METHOXYTYRAMINE IN TISSUES AND THE OCCURRENCE OF THIS AMINE IN BRAIN. Scandinavian journal of clinical and laboratory investigation 1964;16():133-8.

CARLSSON, A; FALCK, B; FUXE, K; HILLARP, NA CELLULAR LOCALIZATION OF MONOAMINES IN THE SPINAL CORD. Acta physiologica Scandinavica 1964;60():112-9.

ANDEN, NE; CARLSSON, A; WALDECK, B RESERPINE-RESISTENT UPTAKE MECHANISMS OF NORADRENALINE IN TISSUES. Life sciences 1963;12():889-94.

CARLSSON, A; JONASSON, J; ROSENGREN, E TIME CORRELATION BETWEEN THE EFFECTS OF RESERPINE ON BEHAVIOUR AND STORAGE MECHANISM FOR ARYLALKYLAMINES. Acta physiologica Scandinavica 1963;59():474-7.

SEIDEN, LS; CARLSSON, A TEMPORARY AND PARTIAL ANTAGONISM BY L-DOPA OF RESERPINE-INDUCED SUPPRESSION OF A CONDITIONED AVOIDANCE RESPONSE. Psychopharmacologia 1963;4():418-23.

CARLSSON, A; MAGNUSSON, T; ROSENGREN, E 5-HYDROXYTRYPTAMINE OF THE SPINAL CORD NORMALLY AND AFTER TRANSECTION. Experientia 1963;19():359.

CARLSSON, A; WALDECK, B BETA-HYDROXYLATION OF TYRAMINE IN VIVO. Acta pharmacologica et toxicologica 1963;20():371-4.

CARLSSON, A; HILLARP, NA; WALDECK, B ANALYSIS OF THE MG++-ATP DEPENDENT STORAGE MECHANISM IN THE AMINE GRANULES OF THE ADRENAL MEDULLA. Acta physiologica Scandinavica. Supplementum 1963;():SUPPL215:1-38.

CARLSSON, A; LINDQVIST, M EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN. Acta pharmacologica et toxicologica 1963;20():140-4.

CARLSSON, A; WALDECK, B ON THE ROLE OF THE LIVER CATECHOL-O-METHYL TRANSFERASE IN THE METABOLISM OF CIRCULATING CATECHOLAMINES. Acta pharmacologica et toxicologica 1963;20():47-55.

CARLSSON, A; HILLARP, NA Formation of phenolic acids in brain after administration of 3,4-dihydroxyphenylalanine. Acta physiologica Scandinavica 1962;55():95-100.

CARLSSON, A; FALCK, B; HILLARP, NA; TORP, A Histochemical localization at the cellular level of hypothalamic noradrenaline. Acta physiologica Scandinavica 1962;54():385-6.

CARLSSON, A; FALCK, B; HILLARP, NA Cellular localization of brain monoamines. Acta physiologica Scandinavica. Supplementum 1962;56(196):1-28.

CARLSSON, A; LINDQVIST, M In-vivo decarboxylation of alpha-methyl DOPA and alpha-methyl metatyrosine. Acta physiologica Scandinavica 1962;54():87-94.

CARLSSON, A; LINDQVIST, M A method for the determination of normetanephrine in brain. Acta physiologica Scandinavica 1962;54():83-6.

CARLSSON, A; HILLARP, NA; WALDECK, B A Mg-ATP dependent storage mechanism in the amine granules of the adrenal medulla. Medicina experimentalis. International journal of experimental medicine 1962;6():47-53.

CARLSSON, A; HILLARP, NA Uptake of phenyl and indole alkylamines by the storage granules of the adrenal medulla in vitro. Medicina experimentalis. International journal of experimental medicine 1961;5():122-4.

CARLSSON, A; FALCK, B; HILLARP, NA; THIEME, G; TORP, A A new histochemical method for visualization of tissue catechol amines. Medicina experimentalis. International journal of experimental medicine 1961;4():123-5.

CARLSSON, A; RASMUSSEN, EB; KRIST JANSEN, P The urinary excretion of adrenaline and noradrenaline by schizophrenic patients during reserpine treatment. Journal of neurochemistry 1959;4():318-20.

CARLSSON, A; RASMUSSEN, EB; KRISTJANSEN, P The urinary excretion of adrenaline and noradrenaline by depressive patients during iproniazid treatment. Journal of neurochemistry 1959;4():321-4.

CARLSSON, A The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacological reviews 1959;11(2, Part 2):490-3.

CARLSSON, A Detection and assay of dopamine. Pharmacological reviews 1959;11(2, Part 2):300-4.

BERTLER, A; CARLSSON, A; ROSENGREN, E Fluorimetric method for differential estimation of the 3-O-methylated derivatives of adrenaline and noradrenaline (metanephrine and normetanephrine. Clinica chimica acta; international journal of clinical chemistry 1959;4(3):456-7.

CARLSSON, A; WALDECK, B A fluorimetric method for the determination of dopamine (3-hydroxytyramine). Acta physiologica Scandinavica 1958;44(3-4):293-8.

BERTLER, A; CARLSSON, A; ROSENGREN, E A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta physiologica Scandinavica 1958;44(3-4):273-92.

CARLSSON, A; HILLARP, NA On the state of the catechol amines of the adrenal medullary granules. Acta physiologica Scandinavica 1958;44(2):163-9.

BERTLER, A; CARLSSON, A; LINDQVIST, M; MAGNUSSON, T On the catehol amine in blood plasma after stimulation of the sympathoadrenal system. Experientia 1958;14(5):184-5.

CARLSSON, A; LINDQVIST, M; MAGNUSSON, T; WALDECK, B On the presence of 3-hydroxytyramine in brain. Science (New York, N.Y.) 1958;127(3296):471.

CARLSSON, A; LINDQVIST, M; MAGNUSSON, T 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 1957;180(4596):1200.

CARLSSON, A; SHORE, PA; BRODIE, BB Release of serotonin from blood platelets by reserpine in vitro. The Journal of pharmacology and experimental therapeutics 1957;120(3):334-9.

CARLSSON, A; HILLARP, NA; HOKFELT, B The concomitant release of adenosine triphosphate and catechol amines from the adrenal medulla. The Journal of biological chemistry 1957;227(1):243-52.

SHORE, PA; PLETSCHER, A; TOMICH, EG; CARLSSON, A; KUNTZMAN, R; BRODIE, BB Role of brain serotonin in reserpine action. Annals of the New York Academy of Sciences 1957;66(3):609-15; discussion, 615-7.

CARLSSON, A; HILLARP, NA Release of adenosine triphosphate along with adrenaline and noradrenaline following stimulation of the adrenal medulla. Acta physiologica Scandinavica 1956;37(2-3):235-9.

CARLSSON, A; MAGNUSSON, T Failure to demonstrate antipyretic and analgesic properties of salicylamides. Acta pharmacologica et toxicologica 1955;11(3):248-53.



Videos of Arvid Carlsson



Photos of Arvid Carlsson

Comments are closed.

  • Postings

    Professor Emeritus
    University of Goteborg